The metabolic syndrome, comprising obesity, glucose intolerance, dyslipidemia, hypertension, and insulin resistance, is associated with a high risk of cardiovascular disease. Several studies have shown that obesity is associated with low levels of B-type natriuretic peptides (BNP), which, in turn, have been shown to be an adverse risk factor in a number of cardiac conditions. In this issue of Circulation, Wang and colleagues show, in 3333 Framingham subjects without heart failure, that BNP levels were inversely associated with all components of the metabolic syndrome except hypertension. Although these data cannot determine which came first, the low BNP or the metabolic syndrome, the authors suggest that low BNP levels could predispose to insulin resistance and affect lipid and fatty acid metabolism as well as increase inflammation. They also raise the possibility that metabolic traits should be taken into account when interpreting BNP levels. See p 1345.
SIX-MONTH OUTCOME OF EMERGENCY PERCUTANEOUS CORONARY INTERVENTION IN RESUSCITATED PATIENTS AFTER CARDIAC ARREST COMPLICATING ST-ELEVATION MYOCARDIAL INFARCTION, by Garot et al.
The role of percutaneous coronary intervention in patients who are resuscitated from cardiac arrest following an acute ST-elevation myocardial infarction is unclear, and the outcome of these patients is poorly defined. The study by Garot et al retrospectively collected the data from 186 consecutive patients undergoing emergency percutaneous coronary intervention after resuscitated cardiac arrest complicating acute myocardial infarction from 5 centers. Most of the patients were resuscitated out of the hospital by mobile medical care units. Shock was present on admission in 52%. Percutaneous coronary intervention was successful in 87% of the patients. Six-month survival rate was 54%. The multivariable predictors of survival were a short duration between the onset of arrest and the arrival of the first responder and the return of spontaneous circulation and the absence of diabetes. The study supports the use of early revascularization in these patients and reaffirms the importance of prehospital management and early resuscitation. See p 1354.
GLUCOSE LEVELS PREDICT HOSPITALIZATION FOR CONGESTIVE HEART FAILURE IN PATIENTS AT HIGH CARDIOVASCULAR RISK, by Held et al.
The augmented risk of major adverse cardiovascular events in patients with diabetes mellitus is consistent across epidemiological and clinical trial databases. Held and colleagues explored the baseline testing glucose levels of over 30 000 patients in the ONTARGET (Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial) and TRANSCEND (Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease) trials and found an association between elevated glucose levels and risk of being hospitalized for heart failure. The significance of this association persisted after adjusting for other risk factors, including the diagnosis of diabetes. Petrie and McMurray underscore the novel data of an association with dysglycemia and heart failure risk in patients not characterized as having diabetes in their accompanying editorial. See p 1371 (editorial on p 1334).
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